MARCH 30, 2007
VOLUME 4 NO. 6

PATIENTS & PRACTICE

Kidney stone Tx review results in draw

Best practices urgently needed for ureteroscopy, shock wave therapy: Cochrane


When it comes to getting rid of kidney stones that won't budge on their own, urologists have two choices: minor surgery or shock wave treatment. The decision on which to use is based on clinical judgement and experience — not least because we have no clear guidelines on which technique is preferable in what circumstances.

Head-to-head trials have been few and far between, and those few are often limited by faulty methodology or sketchy data. Now, the folks at the Cochrane Collaboration have attempted to clear things up. Though they were unable to pick a clear winner, they did note that patients who undergo lithotripsy — shock wave treatment — are less likely to suffer complications or hospitalizations, but are also less likely to be stone-free after treatment.

LIMITED DATA
The team led by Ghulam Nabi of the University of Aberdeen considered six of the best available trials, comprising 833 cases in all. The raw material was admittedly not of the highest quality. "The most important finding from our review is that current practice of managing kidney stones is based on poor-quality evidence, mostly from small trials with a lot of heterogeneity," Dr Nabi said in a press release.

For one thing, the two biggest trials looked at patients with lower kidney stones — those below the lower edge of the pelvis. In real practice, there would be three treatment choices here, not two, because conservative treatment often sees these stones flushed out spontaneously.

Many urologists believe stone location is a key factor in deciding which treatment to use. Ureteroscopy, the gold standard surgical technique, can seem more attractive when the stone is lower, because the ureteroscope need not be inserted so far, and the risk of damage is correspondingly less. But the available data didn't permit the Cochrane researchers to pronounce on this question.

Nor could they address differences in patient characteristics. For example, two previous studies have suggested that lithotripsy has a higher failure rate in obese patients.

In fact, many questions remain unanswered because the data is so sparse and contradictory. Four studies in the analysis compared the time taken to remove stones. Two found ureteroscopy a swifter procedure, while two declared lithotripsy faster.

TECH CHALLENGE
Much of the confusion is really due to changing technology. Ureteroscopy was always acknowledged to have a high complication rate. As the surgeon pulls out the stone with a basket or forceps attachment, the potential for tissue damage or even perforation is clear.

The lithotripter offered a welcome alternative to ureteroscopy. But since then, it's the older technique that has come on by leaps and bounds, while new improvements in lithotripters remain very much at the prototype stage.

The introduction of the Holmium: YAG laser allows the surgeon performing a ureteroscopy the option of ablating the stone before dragging it out. And the miniaturization of components has permitted narrower, more flexible ureteroscopes, reducing the threat of scarring and bleeding.

Even the six trials in the Cochrane analysis, all less than eight years old, are now somewhat obsolete because they took place when ureteroscopy was commonly followed by stenting of the ureter. That practise is increasingly being abandoned due to pain complications.

KNOW WHAT'S BEST
Ultimately, the group concludes, physicians should consider what equipment is available, and what is usable in the particular. If a small-calibre ureteroscope is feasible and the stone is readily accessible, that might be the best option.

Not all lithotriptor machines are equal, and the newest may not be the best. The original machine, the HM3 made by Dornier, is a large, clunky thing with a rather crude focus. That broader focal zone can increase discomfort, but it also minimizes the chance of missing part of the stone. Dornier's newer offering, the portable HM4, is more refined but has been linked to lower stone-free rates.

The Cochrane researchers argue that if any research should take priority, it would be studies that seek to establish best practices in both lithotripsy and ureteroscopy. Only once we know that can we usefully compare the two against each other.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T. (514) 995-4398